United States - English - NLM (National Library of Medicine)

strides pharma science limited - zafirlukast (unii: xz629s5l50) (zafirlukast - unii:xz629s5l50) - accolate is indicated for the prophylaxis and chronic treatment of asthma in adults and children 5 years of age and older. accolate is contraindicated in patients who are hypersensitive to zafirlukast or any of its inactive ingredients. accolate is contraindicated in patients with hepatic impairment including hepatic cirrhosis.

New Zealand - English - Medsafe (Medicines Safety Authority)

astrazeneca limited - zafirlukast 20mg;  ;   - tablet - 20 mg - active: zafirlukast 20mg     excipient: croscarmellose sodium hypromellose lactose monohydrate magnesium stearate microcrystalline cellulose povidone purified water   titanium dioxide

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

waymade healthcare plc - zafirlukast - oral tablet - 20mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

dowelhurst ltd - zafirlukast - oral tablet - 20mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

de pharmaceuticals - zafirlukast - oral tablet - 20mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

sigma pharmaceuticals plc - zafirlukast - oral tablet - 20mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

lexon (uk) ltd - zafirlukast - oral tablet - 20mg

Bangladesh - English - DGDA (Directorate General of Drug Administration)

alco pharma limited - zafirlukast - tablet - 20 mg

Bangladesh - English - DGDA (Directorate General of Drug Administration)

beximco pharmaceuticals ltd. - zafirlukast - tablet - 20 mg

Bangladesh - English - DGDA (Directorate General of Drug Administration)

eskayef pharmaceuticals ltd. mirpur. - zafirlukast - tablet - 20 mg